Depression history as a predictor of outcomes during buprenorphine-naloxone treatment of prescription opioid use disorder – Peckham AD, Griffin ML, McHugh RK, Weiss RD.

BACKGROUND: In the multi-site Prescription Opioid Addiction Treatment Study (POATS), the best predictor of successful opioid use outcome was lifetime diagnosis of major depressive disorder. The primary aim of this secondary analysis of data from POATS was … (Source: SafetyLit)